Conditions: Diabetes Mellitus, Type 2 Healthy
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 39
Healthy volunteers: yes

Brief summary:
Single center, 14-day, open-label trial to examine the effect of 25 mg q.d. empagliflozin on kinetics of renal glucose reabsorption in patients diagnosed with type 2 diabetes mellitus and healthy controls

Detailed description:

Arms:
arm 1: healthy controls arm 2: patients with type 2 diabetes mellitus

Interventions: intervention 1: Empagliflozin intervention 2: BI 10773
Intervention descriptions: intervention 1: None intervention 2: open label

Protocol document: